Vitamin D Biosynthesis and Hormonal Regulation

Astrocytes (a type of glia) were identified in neural tissue cell cultures using specific staining techniques.
DAPI: A fluorescent stain used to identify nuclear material; it typically stains one nucleus per cell blue.
Glial Fibrillary Acidic Protein (GFAP): A cytoskeletal protein used as an identifying marker for astrocytes via immunohistochemistry (IHC).

Receptor Location: Immunohistochemistry demonstrates that VDR occurs in the cytosol of the cell rather than on the cell surface.
Visual Evidence: In a $2 ext{D}$ view, receptors appear less dense over the nucleus because there is less cytosol present between the cell surface and the nucleus in that region.
Hormone Action: Upon binding with Vitamin D, the VDR translocates from the cytosol into the nucleus to regulate gene transcription.

Skin Synthesis: Keratinocytes produce $7 ext{-dehydrocholesterol}$ via the smooth endoplasmic reticulum.
Photoconversion: Exposure to UVB radiation ( $285-305 ext{ nm}$ ) converts $7 ext{-dehydrocholesterol}$ into pre-vitamin D.
Liver Processing: The liver adds a hydroxyl group at the $25^{ ext{th}}$ carbon position to produce the storage form, $25 ext{-hydroxyvitamin D}_3$ .
Kidney Activation: Stimulated by parathyroid hormone (PTH), the kidney produces $1 ext{-alpha-hydroxylase}$ . This enzyme adds a second hydroxyl group at the $1$ position to create the active form, $1,25 ext{-dihydroxyvitamin D}$ .

Hormonal Type: Vitamin D is a steroid-based hormone that requires a protein carrier for transport through the bloodstream.
Target Organs: Active Vitamin D acts on the intestines, kidneys, and bone.
Calcium Elevation: Vitamin D increases blood calcium by: * Activating osteoclasts to degrade bone. * Increasing intestinal calcium absorption. * Promoting renal calcium reabsorption from urine.
Negative Feedback: Elevated blood calcium levels eventually suppress PTH, leading to the deposition of calcium back into the bone once stable levels are achieved.